ATE330615T1 - Doxycyclin zur behandlung von akne - Google Patents

Doxycyclin zur behandlung von akne

Info

Publication number
ATE330615T1
ATE330615T1 AT02731267T AT02731267T ATE330615T1 AT E330615 T1 ATE330615 T1 AT E330615T1 AT 02731267 T AT02731267 T AT 02731267T AT 02731267 T AT02731267 T AT 02731267T AT E330615 T1 ATE330615 T1 AT E330615T1
Authority
AT
Austria
Prior art keywords
doxycycline
treating acne
human
acne
administering
Prior art date
Application number
AT02731267T
Other languages
English (en)
Inventor
Robert A Ashley
Original Assignee
Collagenex Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE330615(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collagenex Pharm Inc filed Critical Collagenex Pharm Inc
Application granted granted Critical
Publication of ATE330615T1 publication Critical patent/ATE330615T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02731267T 2001-04-05 2002-04-05 Doxycyclin zur behandlung von akne ATE330615T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05

Publications (1)

Publication Number Publication Date
ATE330615T1 true ATE330615T1 (de) 2006-07-15

Family

ID=23079310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731267T ATE330615T1 (de) 2001-04-05 2002-04-05 Doxycyclin zur behandlung von akne

Country Status (12)

Country Link
EP (4) EP2221056A1 (de)
JP (3) JP2004536046A (de)
KR (1) KR100926326B1 (de)
AT (1) ATE330615T1 (de)
AU (1) AU2002303250B2 (de)
CA (2) CA2440472C (de)
DE (1) DE60212613T2 (de)
DK (1) DK1383508T3 (de)
ES (1) ES2266499T3 (de)
NZ (1) NZ528197A (de)
PT (1) PT1383508E (de)
WO (1) WO2002080932A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551708T3 (es) * 2002-01-08 2015-11-23 Paratek Pharmaceuticals, Inc. Compuestos de 4-desdimetilamino tetraciclina
CA2476792A1 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
CA2894736C (en) 2003-04-07 2019-07-16 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
NZ544826A (en) 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
WO2005046618A2 (en) * 2003-11-06 2005-05-26 Research Foundation Of State University Of New York, The Methods of treating eczema
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
KR20090122994A (ko) * 2007-03-23 2009-12-01 몰레큘러 리서치 센터, 인크. 테트라사이클린류를 함유하는 항염증성 조성물 및 이의 치료 용도
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
MX2010012385A (es) * 2008-05-16 2010-12-02 Galderma Res & Dev Regimen de terapia para tratar enfermedades relacionadas al acne.
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
EP2838518B1 (de) * 2012-04-19 2018-02-21 Galderma S.A. Verfahren zur behandlung von akne
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
AU2018303807B2 (en) * 2017-07-21 2023-08-24 Almirall, Llc Treatment of non-inflammatory lesions
WO2019135166A1 (en) 2018-01-07 2019-07-11 Dr. Reddy's Laboratories Ltd. Minocycline for treating inflammatory skin conditions
CA3125456A1 (en) 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278457D1 (en) * 1981-08-27 1988-06-16 Soft Sheen Products Inc Use of carbamide peroxide for the manufacture of a medicament for treatment of acne vulgaris
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
EP0543811B1 (de) * 1990-08-16 2000-07-12 Bloom, Leonard Topische behandlung von blepharitis
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
JP2002525299A (ja) * 1998-09-28 2002-08-13 ザ リサーチ ファウンデーション オブ ステイト ユニヴァーシティ オブ ニューヨーク 新規白内障形成抑制剤
ATE336238T1 (de) * 1998-11-18 2006-09-15 Collagenex Pharm Inc Neue 4-dedimethylaminotetracyclinderivate
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

Also Published As

Publication number Publication date
CA2440472A1 (en) 2002-10-17
EP1712236A3 (de) 2008-05-28
KR100926326B1 (ko) 2009-11-12
ES2266499T3 (es) 2007-03-01
KR20040007488A (ko) 2004-01-24
EP1716856A2 (de) 2006-11-02
DE60212613T2 (de) 2007-05-24
DE60212613D1 (de) 2006-08-03
CA2719162C (en) 2014-12-23
EP1712236A2 (de) 2006-10-18
WO2002080932A1 (en) 2002-10-17
DK1383508T3 (da) 2006-12-27
AU2002303250B2 (en) 2006-05-25
EP2221056A1 (de) 2010-08-25
NZ528197A (en) 2007-04-27
JP2011168613A (ja) 2011-09-01
EP1383508A1 (de) 2004-01-28
PT1383508E (pt) 2006-11-30
EP1383508B1 (de) 2006-06-21
CA2440472C (en) 2011-01-18
JP2004536046A (ja) 2004-12-02
JP2010053155A (ja) 2010-03-11
EP1716856A3 (de) 2009-02-18
CA2719162A1 (en) 2002-10-17
EP1383508A4 (de) 2005-07-06

Similar Documents

Publication Publication Date Title
DE60212613D1 (de) Doxycyclin zur behandlung von akne
WO2005046618A3 (en) Methods of treating eczema
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
EA200900540A1 (ru) Замещённые соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
ATE399547T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia
EA201001081A1 (ru) Соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
DK0923378T3 (da) Fremme af sårheling ved kemisk modificerede tetracykliner
EA200300134A1 (ru) Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
WO2003088906A3 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
DK0946166T3 (da) Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling
DE60326273D1 (de) Verfahren und verbindungen zur verstärkung der fybrozyten-bildung
BR0308813A (pt) Tratamento de tuberculose usando derivados de pleuromutilina
ATE191472T1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
DE69512589D1 (de) Behandlung von durch Talgdrüse verursachten Erkrankungen mit Inhibitoren der Acyl CoA Cholesterin Acyltransferase
TR200401669T1 (tr) Neoplastik hastalıkların tedavisi için metarix-metalloproteinazları önleyen kompozisyon.
DE69941966D1 (de) Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
ATE463242T1 (de) Behandlung von inkontinenz
ATE393625T1 (de) Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen
ATE293972T1 (de) Behandlung von chronischen schmerzen
DE60335093D1 (de) Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen
ATE428436T1 (de) Mittel zur behandlung oder prävention allergischer erkrankungen mit bearbeitetem erdnusssamen-überzug
DE60108775T8 (de) Methode zur behandlung von schlaganfall
DE60141994D1 (de) 13-substituierte Methacyclinverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1383508

Country of ref document: EP